ID   DPOE4_HUMAN             Reviewed;         117 AA.
AC   Q9NR33; Q53TR2;
DT   30-AUG-2002, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   10-MAY-2017, entry version 133.
DE   RecName: Full=DNA polymerase epsilon subunit 4;
DE            EC=2.7.7.7;
DE   AltName: Full=DNA polymerase II subunit 4;
DE   AltName: Full=DNA polymerase epsilon subunit p12;
GN   Name=POLE4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], IDENTIFICATION IN EPSILON DNA
RP   POLYMERASE COMPLEX, AND VARIANT VAL-17.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=10801849; DOI=10.1074/jbc.M002548200;
RA   Li Y., Pursell Z.F., Linn S.;
RT   "Identification and cloning of two histone fold motif-containing
RT   subunits of HeLa DNA polymerase epsilon.";
RL   J. Biol. Chem. 275:23247-23252(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-17.
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25, VARIANT [LARGE SCALE
RP   ANALYSIS] VAL-17, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [5]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT THR-11, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: May play a role in allowing polymerase epsilon to carry
CC       out its replication and/or repair function.
CC   -!- CATALYTIC ACTIVITY: Deoxynucleoside triphosphate + DNA(n) =
CC       diphosphate + DNA(n+1).
CC   -!- SUBUNIT: Component of the epsilon DNA polymerase complex
CC       consisting of four subunits: POLE, POLE2, POLE3 and POLE4.
CC       Interaction with POLE3 is a prerequisite for further binding with
CC       POLE and POLE2. {ECO:0000269|PubMed:10801849}.
CC   -!- INTERACTION:
CC       P25208:NFYB; NbExp=9; IntAct=EBI-867034, EBI-389728;
CC       Q9Q2G4:ORF (xeno); NbExp=2; IntAct=EBI-867034, EBI-6248094;
CC       Q9NRF9:POLE3; NbExp=7; IntAct=EBI-867034, EBI-744901;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF261688; AAF90132.1; -; Genomic_DNA.
DR   EMBL; AC007400; AAY15030.1; -; Genomic_DNA.
DR   EMBL; BC031331; AAH31331.1; -; mRNA.
DR   CCDS; CCDS1957.1; -.
DR   RefSeq; NP_063949.2; NM_019896.3.
DR   UniGene; Hs.469060; -.
DR   ProteinModelPortal; Q9NR33; -.
DR   SMR; Q9NR33; -.
DR   BioGrid; 121168; 19.
DR   IntAct; Q9NR33; 9.
DR   MINT; MINT-3072641; -.
DR   STRING; 9606.ENSP00000420176; -.
DR   DrugBank; DB00242; Cladribine.
DR   iPTMnet; Q9NR33; -.
DR   PhosphoSitePlus; Q9NR33; -.
DR   BioMuta; POLE4; -.
DR   DMDM; 116241340; -.
DR   EPD; Q9NR33; -.
DR   MaxQB; Q9NR33; -.
DR   PaxDb; Q9NR33; -.
DR   PeptideAtlas; Q9NR33; -.
DR   PRIDE; Q9NR33; -.
DR   TopDownProteomics; Q9NR33; -.
DR   Ensembl; ENST00000483063; ENSP00000420176; ENSG00000115350.
DR   GeneID; 56655; -.
DR   KEGG; hsa:56655; -.
DR   UCSC; uc002snf.4; human.
DR   CTD; 56655; -.
DR   DisGeNET; 56655; -.
DR   GeneCards; POLE4; -.
DR   H-InvDB; HIX0002198; -.
DR   HGNC; HGNC:18755; POLE4.
DR   HPA; HPA054979; -.
DR   HPA; HPA071815; -.
DR   MIM; 607269; gene.
DR   neXtProt; NX_Q9NR33; -.
DR   OpenTargets; ENSG00000115350; -.
DR   PharmGKB; PA38677; -.
DR   eggNOG; KOG1658; Eukaryota.
DR   eggNOG; ENOG41122NU; LUCA.
DR   GeneTree; ENSGT00530000063560; -.
DR   HOGENOM; HOG000007271; -.
DR   HOVERGEN; HBG051399; -.
DR   InParanoid; Q9NR33; -.
DR   KO; K03506; -.
DR   OMA; MHVATHE; -.
DR   OrthoDB; EOG091G0HN1; -.
DR   PhylomeDB; Q9NR33; -.
DR   TreeFam; TF103009; -.
DR   Reactome; R-HSA-110314; Recognition of DNA damage by PCNA-containing replication complex.
DR   Reactome; R-HSA-174430; Telomere C-strand synthesis initiation.
DR   Reactome; R-HSA-5651801; PCNA-Dependent Long Patch Base Excision Repair.
DR   Reactome; R-HSA-5656169; Termination of translesion DNA synthesis.
DR   Reactome; R-HSA-5685942; HDR through Homologous Recombination (HRR).
DR   Reactome; R-HSA-5696397; Gap-filling DNA repair synthesis and ligation in GG-NER.
DR   Reactome; R-HSA-5696400; Dual Incision in GG-NER.
DR   Reactome; R-HSA-6782135; Dual incision in TC-NER.
DR   Reactome; R-HSA-6782210; Gap-filling DNA repair synthesis and ligation in TC-NER.
DR   Reactome; R-HSA-68952; DNA replication initiation.
DR   Reactome; R-HSA-68962; Activation of the pre-replicative complex.
DR   GenomeRNAi; 56655; -.
DR   PRO; PR:Q9NR33; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115350; -.
DR   CleanEx; HS_POLE4; -.
DR   Genevisible; Q9NR33; HS.
DR   GO; GO:0005671; C:Ada2/Gcn5/Ada3 transcription activator complex; IDA:BHF-UCL.
DR   GO; GO:0008622; C:epsilon DNA polymerase complex; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003887; F:DNA-directed DNA polymerase activity; TAS:ProtInc.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006270; P:DNA replication initiation; TAS:Reactome.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0043966; P:histone H3 acetylation; IDA:BHF-UCL.
DR   GO; GO:0000722; P:telomere maintenance via recombination; TAS:Reactome.
DR   InterPro; IPR003958; CBFA_NFYB_domain.
DR   InterPro; IPR009072; Histone-fold.
DR   Pfam; PF00808; CBFD_NFYB_HMF; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Complete proteome; DNA-binding;
KW   DNA-directed DNA polymerase; Nucleotidyltransferase; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    117       DNA polymerase epsilon subunit 4.
FT                                /FTId=PRO_0000191746.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES      11     11       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES      25     25       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   VARIANT      17     17       G -> V (in dbSNP:rs12366).
FT                                {ECO:0000244|PubMed:17525332,
FT                                ECO:0000269|PubMed:10801849,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_028050.
SQ   SEQUENCE   117 AA;  12209 MW;  1F7273FFEC9D318C CRC64;
     MAAAAAAGSG TPREEEGPAG EAAASQPQAP TSVPGARLSR LPLARVKALV KADPDVTLAG
     QEAIFILARA AELFVETIAK DAYCCAQQGK RKTLQRRDLD NAIEAVDEFA FLEGTLD
//
